HOME   |   PRESS ROOM   |   CONTACT US 

7 a.m.–5 p.m.

Registration Open

8:30–10 a.m.

Plenary 2

10 a.m.–5 p.m.

Exhibit hall is open

10–10:30 a.m.

Refreshment break in exhibit hall

10:30 a.m.–12:30 p.m.

Symposia Sessions

S2-01 Diagnosis & Clinical Course — Biomarkers

S2-02 Disease Mechanisms APP/BETA Amyloid

S2-03 Disease Mechanisms — TAU, Tauopathies

S2-04 Therapeutics: Towards Disease Modification

S2-05 Enhancing Care of Persons with Dementia Through
Coordination of Medical and Community Care

12:30–3 p.m.

Exhibits/Poster Sessions/Lunch on own

3–5 p.m.

Oral Sessions

O2-01 Diagnosis and Clinical Course: Clinical

O2-02 Disease Mechanisms: A Beta

O2-03 Disease Mechanisms: Others

O2-04 Therapeutics 2

O2-05 Disease Mechanisms: Tau,Tauopathies 2

O2-06 Genetic Factors

O2-07 Social and Behavioral Research 1

Evening

Corporate Sponsored Symposium - CME

Early Recognition and treatment of Alzheimer's Disease

Advances in Pharmacologic and Non-pharmacologic Treatments

Corporate Sponsored Symposium - non-CME

Fueling Future Clinical Research: Insights From a Decade of Alzheimer's Disease Clinical Trials